Trials / Completed
CompletedNCT03708770
everlinQ Endovascular Access System Enhancements (EASE) Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 32 (actual)
- Sponsor
- C. R. Bard · Industry
- Sex
- All
- Age
- 18 Years – 90 Years
- Healthy volunteers
- Not accepted
Summary
Prospective, single-center study to evaluate the everlinQ System when used to create an endoAVF in hemodialysis patients.
Detailed description
A total of up to 50 subjects will be enrolled and will undergo an endoAVF creation procedure using the everlinQ System. All subjects will be followed for up to 12 months post index procedure based on Investigator's discretion.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | everlinQ endoAVF System |
Timeline
- Start date
- 2015-07-27
- Primary completion
- 2017-06-19
- Completion
- 2017-06-19
- First posted
- 2018-10-17
- Last updated
- 2025-12-11
- Results posted
- 2019-06-14
Source: ClinicalTrials.gov record NCT03708770. Inclusion in this directory is not an endorsement.